Connection

CHRIS AMOS to Predictive Value of Tests

This is a "connection" page, showing publications CHRIS AMOS has written about Predictive Value of Tests.
Connection Strength

0.570
  1. An EGFR signature predicts cell line and patient sensitivity to multiple tyrosine kinase inhibitors. Int J Cancer. 2020 11 01; 147(9):2621-2633.
    View in: PubMed
    Score: 0.109
  2. Next generation sequencing and its applications in HPV-associated cancers. Oncotarget. 2017 Jan 31; 8(5):8877-8889.
    View in: PubMed
    Score: 0.086
  3. Genomic sequencing in cancer. Cancer Lett. 2013 Nov 01; 340(2):161-70.
    View in: PubMed
    Score: 0.065
  4. Building a statistical model for predicting cancer genes. PLoS One. 2012; 7(11):e49175.
    View in: PubMed
    Score: 0.065
  5. Serum levels of total bile acids are associated with an increased risk of HCC in patients with cirrhosis. Hepatol Commun. 2024 Nov 01; 8(11).
    View in: PubMed
    Score: 0.037
  6. Re: On the use of familial aggregation in population-based case probands for calculating penetrance. J Natl Cancer Inst. 2003 Jan 01; 95(1):74-5; author reply 77-8.
    View in: PubMed
    Score: 0.033
  7. Pan-cancer evaluation of gene expression and somatic alteration data for cancer prognosis prediction. BMC Cancer. 2021 Sep 25; 21(1):1053.
    View in: PubMed
    Score: 0.030
  8. Penetrance Estimates Over Time to First and Second Primary Cancer Diagnosis in Families with Li-Fraumeni Syndrome: A Single Institution Perspective. Cancer Res. 2020 01 15; 80(2):347-353.
    View in: PubMed
    Score: 0.026
  9. Genetic analysis of simulated oligogenic traits in nuclear and extended pedigrees: summary of GAW10 contributions. Genet Epidemiol. 1997; 14(6):719-35.
    View in: PubMed
    Score: 0.021
  10. The effect on melanoma risk of genes previously associated with telomere length. J Natl Cancer Inst. 2014 Oct; 106(10).
    View in: PubMed
    Score: 0.018
  11. DNA repair capacity in peripheral lymphocytes predicts survival of patients with non-small-cell lung cancer treated with first-line platinum-based chemotherapy. J Clin Oncol. 2011 Nov 01; 29(31):4121-8.
    View in: PubMed
    Score: 0.015
  12. Re: Discriminatory accuracy from single-nucleotide polymorphisms in models to predict breast cancer risk. J Natl Cancer Inst. 2009 Dec 16; 101(24):1731-2; author reply 1732.
    View in: PubMed
    Score: 0.013
  13. Mitochondrial DNA content: its genetic heritability and association with renal cell carcinoma. J Natl Cancer Inst. 2008 Aug 06; 100(15):1104-12.
    View in: PubMed
    Score: 0.012
  14. A risk model for prediction of lung cancer. J Natl Cancer Inst. 2007 May 02; 99(9):715-26.
    View in: PubMed
    Score: 0.011
  15. Genetic variations in radiation and chemotherapy drug action pathways predict clinical outcomes in esophageal cancer. J Clin Oncol. 2006 Aug 10; 24(23):3789-98.
    View in: PubMed
    Score: 0.010
  16. Power of a simplified multivariate test for genetic linkage. Ann Hum Genet. 2002 Nov; 66(Pt 5-6):407-17.
    View in: PubMed
    Score: 0.008
  17. Chromosome breaks and sister chromatid exchange as predictors of second cancers in Hodgkin's disease. Leuk Lymphoma. 1998 Feb; 28(5-6):561-6.
    View in: PubMed
    Score: 0.006
  18. Mutagen sensitivity as a risk factor for second malignant tumors following malignancies of the upper aerodigestive tract. J Natl Cancer Inst. 1994 Nov 16; 86(22):1681-4.
    View in: PubMed
    Score: 0.005
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.